Supernus Pharmaceuticals | SUPN - Credores Comerciais





Credores Comerciais Alterar Data
Abbott USD 4.24B 117M 2025-12
ANI Pharmaceuticals USD 62.58M 7.21M 2025-12
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Canopy Growth CAD 19.96M 1.83M 2025-12
Cara Therapeutics USD 4.08M 1.65M 2025-09
Corcept Therapeutics USD 40.44M 6M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Novo Nordisk DKK 19.76B 4.15B 2025-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12